Fact Sheet

About Illumina

Illumina is a leading developer, manufacturer, and marketer of life science tools and integrated systems for large-scale analysis of genetic variation and function. These systems are enabling studies that were not even imaginable just a few years ago, and moving us closer to the realization of personalized medicine. With rapid advances in technology taking place, it is mission-critical to offer solutions that are not only innovative, but flexible, and scalable, with industry-leading support and service.

We strive to meet this challenge by placing a high value on collaborative interactions, rapid delivery of solutions, and meeting the needs of our customers.

Our customers include a broad range of academic, government, pharmaceutical, biotechnology, and other leading institutions around the globe.

Download Illumina @ a Glance Fact Sheet
Quick facts
  • Website:
  • Ticker symbol:
  • Headquarters:
    San Diego, California, USA
  • Number of employees:
    >9,100 globally
  • 2021 revenue1:
    $4.5B USD
  • Illumina @ a Glance
    Fact Sheet
  • Company profile
    Source Book

The Illumina mission

We take our mission seriously and ingrain it in everything we do.

Our mission statement:
To improve human health by unlocking the power of the genome.

Leading-edge products and services

Illumina has developed a comprehensive line of products that address the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. Our broad portfolio of leading-edge sequencing and array-based solutions addresses a range of genomic complexity and throughput, enabling researchers to select the best solution for their scientific challenge.


  • NovaSeq Sequencing Systems
  • NextSeq Sequencing Systems
  • NextSeqDX Sequencing System
  • MiSeq Sequencing System
  • MiSeqDx Sequencing System
  • MiniSeq Sequencing System
  • iSeq 100 System
  • iScan Array Scanner


  • AmpliSeq for Illumina
  • TruSeq, TruSight, and Nextera technologies
  • Infinium genotyping and methylation assays

Where we operate

  • San Diego, California, USA
  • Foster City, California, USA
  • Hayward, California, USA
  • Baltimore, Maryland, USA
  • Madison, Wisconsin, USA
  • São Paulo, Brazil
  • Évry, France
  • Berlin, Germany
  • Eindhoven, Netherlands
  • Cambridge, UK
  • Beijing, China
  • Shanghai, China
  • Singapore
  • Osaka, Japan
  • Tokyo, Japan
  • Seoul, South Korea
  • Melbourne, Australia

Illumina Management Team

  • Francis deSouza
    President & Chief Executive Officer
  • Dr. Alex Aravanis, MD, PhD
    Senior Vice President & Chief Technology Officer
  • Nicole Berry
    Senior Vice President & General Manager of Commercial Operations–Americas Region
  • Juliet Cunningham
    Vice President, Investor Relations
  • Charles Dadswell
    Senior Vice President & General Counsel
  • Paula Dowdy
    Senior Vice President & General Manager, Commercial Operations—Europe, Middle East and Africa
  • Dr. Phil Febbo
    Chief Medical Officer
  • Joydeep Goswami, PhD
    Senior Vice President of Corporate Development and Strategic Planning
  • Aimee Hoyt
    Senior Vice President & Chief People Officer
  • Li Qing
    Vice President & General Manager, Greater China
  • Steve Phillpott
    Senior Vice President & Chief Information Officer
  • Bob Ragusa
    Senior Vice President, Global Quality & Operations
  • Kathryne Reeves
    Senior Vice President & Chief Marketing Officer
  • Mostafa Ronaghi, PhD
    Senior Vice President & Chief Technology Officer
  • Jacquie Ross
    Vice President of Corporate Communications & Corporate Social Responsibility
  • Sam Samad
    Senior Vice President & Chief Financial Officer
  • Susan Tousi
    Senior Vice President & Chief Product Officer
  • Mark Van Oene
    Senior Vice President & Chief Commercial Officer
  • Gretchen Weightman
    Vice President & General Manager—Asia Pacific & Japan
  1. 2021 Annual Revenue provided in February 2022